Mostrar registro simples

dc.contributor.authorFayh, Ana Paula Trussardipt_BR
dc.contributor.authorSapata, Katiuce Borgespt_BR
dc.contributor.authorCunha, Giovani dos Santospt_BR
dc.contributor.authorKrause, Maurício da Silvapt_BR
dc.contributor.authorRocha, Ricardopt_BR
dc.contributor.authorBittencourt Junior, Paulo Ivo Homem dept_BR
dc.contributor.authorMoreira, Jose Claudio Fonsecapt_BR
dc.contributor.authorFriedman, Rogériopt_BR
dc.contributor.authorRossato, Juliane da Silvapt_BR
dc.contributor.authorFernandes, João Robertopt_BR
dc.contributor.authorOliveira, Álvaro Reischak dept_BR
dc.date.accessioned2018-05-11T02:33:23Zpt_BR
dc.date.issued2018pt_BR
dc.identifier.issn1550-2783pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/178124pt_BR
dc.description.abstractBackground: The relationship between diabetes and oxidative stress has been previously reported. Exercise represents a useful non-pharmacological strategy for the treatment in type 2 diabetic (T2DM) patients, but high intensity exercise can induce a transient inflammatory state and increase oxidative stress. Nutritional strategies that may contribute to the reduction of oxidative stress induced by acute exercise are necessary. The aim of this study was to examine if n-3 PUFA supplementation intervention can attenuate the inflammatory response and oxidative stress associated with high intensity exercise in this population. As a primary outcome, lipoperoxidation measurements (TBARS and F2-isoprostanes) were selected. Methods: Thirty T2DM patients, without chronic complications, were randomly allocated into two groups: placebo (gelatin capsules) or n-3 PUFA (capsules containing 180 mg of eicosapentaenoic acid and 120 mg of docosahexaenoic acid). Blood samples were collected fasting before and after 8 weeks supplementation. In the beginning and at the end of protocol, an acute exercise was performed (treadmill), and new blood samples were collected before and immediately after the exercise for measurements of oxidative stress and high-sensitivity C-reactive protein (hs-CRP). Results: After the supplementation period, a decrease in triglycerides levels was observed only in n-3 PUFA supplementation group (mean difference and 95% CI of 0.002 (0.000–0.004), p = 0.005). Supplementation also significantly reduced TRAP levels after exercise (mean difference and 95% CI to 9641 (− 20,068–39,351) for − 33,884 (− 56,976 - -10,793), p = 0.004, Cohen’s d effect size = 1.12), but no significant difference was observed in n-3 PUFA supplementation group in lipoperoxidation parameters as TBARS (mean difference and 95% CI to − 3.8 (− 10–2.4) for − 2.9 (− 1.6–7.4) or F2-isoprostanes (mean difference and 95% CI -0.05 (− 0.19–0.10) for − 0.02 (− 0.19–0.16), p > 0.05 for both. Conclusion: PUFA n-3 supplementation reduced triglycerides as well as TRAP levels after exercise, without a significant effect on inflammatory and oxidative stress markers. This study is registered at ClinicalTrials.gov with the registration number of NCT03182712.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofJournal of the international society of sports nutrition. Woodland Park. Vol. 15 (Apr. 2018), 18, [9 p.]pt_BR
dc.rightsOpen Accessen
dc.subjectOmega-3en
dc.subjectÁcidos graxos ômega-3pt_BR
dc.subjectEstresse oxidativopt_BR
dc.subjectType 2 diabetesen
dc.subjectAcute exerciseen
dc.subjectInflamaçãopt_BR
dc.subjectExercíciopt_BR
dc.subjectOxidative stressen
dc.subjectDiabetes mellitus tipo 2pt_BR
dc.subjectInflammationen
dc.titleEffects of n-3 fatty acids and exercise on oxidative stress parameters in type 2 diabetic : a randomized clinical trialpt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001066609pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples